Position in JNJ
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$5,218,829
+$386,006 QoQ
Shares Held
20,549
+3.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.00%
of 13F equity value
Holder Rank
#1,590
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Southland Equity Partners LLC holds $15,588,502 across 9 Drug Manufacturers - General names. JNJ ranks #2 (33.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,242 | $7,106,816 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
20,549 | $5,218,829 | |
| 3 | LLY |
ELI LILLY & Co
|
693 | $831,205 | |
| 4 | NVS |
Novartis AG
|
3,807 | $596,633 | |
| 5 | AMGN |
Amgen Inc
|
1,418 | $513,486 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,452 | $436,125 | |
| 7 | NVO |
Novo Nordisk A S
|
7,811 | $374,459 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,154 | $276,789 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,218,829 | 20,549 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $4,832,823 | 19,771 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $4,181,010 | 20,203 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $3,885,290 | 20,954 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $3,307,190 | 21,651 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $3,562,574 | 21,482 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $3,245,272 | 22,440 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $3,004,592 | 18,540 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,780,813 | 12,184 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,465,155 | 9,262 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,215,048 | 7,752 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $1,176,379 | 7,553 | Shares | Sole | 2024-01-02 | |
| 2023-06-30 | $1,209,785 | 7,309 | Shares | Sole | 2024-01-02 | |
| 2023-03-31 | $746,635 | 4,817 | Shares | Sole | 2024-01-02 | |
| 2022-12-31 | $810,470 | 4,588 | Shares | Sole | 2024-01-02 | |
| 2022-09-30 | $676,473 | 4,141 | Shares | Sole | 2024-01-02 | |
| 2022-06-30 | $786,546 | 4,431 | Shares | Sole | 2024-01-02 | |
| 2022-03-31 | $784,951 | 4,429 | Shares | Sole | 2024-01-02 | |
| 2021-12-31 | $736,456 | 4,305 | Shares | Sole | 2024-01-02 | |
| 2021-09-30 | $685,406 | 4,244 | Shares | Sole | 2024-01-02 | |
| 2021-06-30 | $685,318 | 4,160 | Shares | Sole | 2024-01-02 | |
| 2021-03-31 | $616,476 | 3,751 | Shares | Sole | 2024-01-02 | |
| 2020-12-31 | $559,171 | 3,553 | Shares | Sole | 2024-01-02 | |
| No filing history on record for this holder in this stock. | ||||||